Home › Amyloidosis › Illinois › Chicago

Amyloidosis clinical trials in Chicago, IL

5 studies for Amyloidosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

RecruitingObservational study

Research Site, Chicago

Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

RecruitingPhase 3

Clinical Trial Site, Chicago

Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

RecruitingPhase 3

Clinical Trial Site, Chicago

Ages 18 to 85 · All sexes · Updated Sep 15, 2026 · NCT07223203

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

RecruitingPhase 3

John H. Stroger, Jr. Hospital of Cook County, Chicago
University of Chicago - Medical Center, Chicago

Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

RecruitingPhase 3

Northwestern University, Chicago

Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629

About Amyloidosis

Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.

More about Amyloidosis on MedlinePlus

Amyloidosis trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.